CN Patent

CN107913258A — 一种左乙拉西坦缓释片及其制备方法

Assigned to Beijing Fukangren Bio Pharm Tech Co Ltd · Expires 2018-04-17 · 8y expired

What this patent protects

一种左乙拉西坦缓释片及其制备方法，本发明公开了含左乙拉西坦的药物组合物，该药物组合物包括水溶性活性成分左乙拉西坦，本发明的左乙拉西坦片剂处方合理，制备工艺稳定，对辅料的选择达到较好的效果，生产成本较低，工艺简单适合于商业化大生产。

USPTO Abstract

一种左乙拉西坦缓释片及其制备方法，本发明公开了含左乙拉西坦的药物组合物，该药物组合物包括水溶性活性成分左乙拉西坦，本发明的左乙拉西坦片剂处方合理，制备工艺稳定，对辅料的选择达到较好的效果，生产成本较低，工艺简单适合于商业化大生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN107913258A
Jurisdiction
CN
Classification
—
Expires
2018-04-17
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Fukangren Bio Pharm Tech Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.